NEW YORK, October 26, 2018 /PRNewswire/ —
According to a research report by Technavio, the legal cannabis market is projected to grow at a CAGR of about 24% until 2021. The widespread proliferation of cannabidiol (CBD) oil products is one of the key growth factors for this growing market. Additionally, the presence of online retailers is also projected to significantly impact sales rates. The medical applications of CBD, as well as the increasing awareness of them, is what supports this segment of the industry. Technavio’s Research analysis of the global CBD oil market indicates that CBD oil is highly recommended because it can suppress the growth of cancer cells and helps in the fight to prevent cancer itself. Focusing on the CBD segment, the research predicts that it will grow at a CAGR of more than 39% by 2021. CLS Holdings USA Inc. (OTC: CLSH), Pyxus International Inc. (NYSE: PYX), iAnthus Capital Holdings, Inc. (OTC: ITHUF), Origin House (OTC: ORHOF), Neptune Wellness Solutions Inc. (NASDAQ: NEPT)
A report by Deloitte indicates similarities between the legal Cannabis industry and alcohol.
“The legalization of recreational cannabis will mark an important change in Canadian society. In time, we expect legalization will legitimize consumption and diminish the stigma that surrounds it today. After all, we’ve been here before-and we’ve shown that we have the maturity to develop strong, thriving industries based on tightly regulated, controlled substances such as beer, wine, and spirits. It was not all that long ago that these were regarded in a vastly different light. In our view, cannabis will prove little different. Recreational consumption will eventually become normalized and mainstream, eliciting about as much reaction as having a pint of craft beer,” Deloitte explained.
CLS Holdings, USA Inc. (OTCQB: CLSH) earlier this month announced that, “it has entered into an agreement with a Canadian agent (the “Agent”), whereby the Agent will assist the Company in selling on a commercially reasonable efforts private placement basis, up to US$40 million aggregate principal amount of senior unsecured debentures (“Debentures”) with an issue price of US$1,000 per Debenture, convertible into units of the Company (the “Units”) at the option of the holder at a conversion price of US$0.80 per Unit (the “Conversion Price”) at any time prior to the close of business on the earlier of: (i) the last business day immediately preceding the maturity date of the Debentures, being the date that is three (3) years from the closing date of the Offering (the “Closing Date”), and (ii) the date fixed for redemption (as set out in the Debentures (the “Offering”). Each Unit shall be comprised of one common share of the Company (a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant shall be exercisable into one Common Share at a price of US$1.10 per Warrant (the “Exercise Price”) for a period of 36 months from the Closing Date… The Company intends to use the net proceeds of the Offering to fund the upfront loan payment to In Good Health Inc., to fund construction activities at the Leicester facility, to complete improvements to the North Las Vegas cultivation facility and for general working capital purposes.”
On September 17th, 2018 CLS Holdings USA Inc. also announced that, “it has executed two Letters of Intent (LOIs) to enter the rapidly growing Massachusetts market. CLS looks forward to the opportunity to enter the Massachusetts market, which has been operating as a legalized medical jurisdiction since 2015 and has approved legalized recreational use.
CLS has agreed in principle to loan $5 million to In Good Health, a licensed medical dispensary in Brockton, Massachusetts with a significant market share. Along with the loan, CLS will have an option to acquire InGood Health. InGood Health is located 25 miles south of downtown Boston and is one of the 38 licensed dispensaries in the state. The Brockton dispensary was the second licensed dispensary in the state and has been operational since September 2015, which has been medical only up until this time. In Good Health is currently servicing 17,000 registered patients and delivering to 1,700 homes with key product offerings of flower, concentrates, vapes, edibles, pre-rolls and tinctures. CLS has also agreed in principle to form an 80/20 joint venture with CannAssist, which CLS will own 80%. CannAssist plans to build out a recreationally licensed cultivation grow facility in Leicester, Massachusetts. The planned Leicester 86,000 square foot facility is in possession of its host community agreement, is awaiting state acknowledgement of its pending recreational licenses and upon completion will be the third largest cultivation grow in the state. The Leicester facility is anticipated to produce its first harvest in the fourth quarter of 2019 and be able to produce 28,000 lbs of flower along with 858,000 grams of extract once it is operating at capacity. At current pricing of $3,500 per pound of flower and $40 per gram of extract, total capacity is expected to reach $120 million in revenue. CLS anticipates generating substantial positive cash flow from the joint venture. Massachusetts has a population of 6.9 million people as compared to 5.6 million people in Colorado. Massachusetts is also centrally located to the dense population of New England with a less than 100-mile drive from Rhode Island, Connecticut, New York, New Hampshire and Vermont. In 2017, Colorado generated $1.5 billion in legalized marijuana sales and had over 500 licensed dispensaries and over 700 licensed cultivation facilities. Massachusetts currently has issued only 39 licensees.
Jeff Binder, Chief Executive Officer of CLS Holdings USA, commented, ‘We are extremely excited to have the opportunity to enter the Massachusetts market. It’s something we have been eyeing for a long time given the attractive characteristics and recent approval of adult use cannabis. This opportunity fits into our stated objective of entering markets that are on the cusp of implementing a robust adult use market.’
David Noble, President of InGood Health and Partner of CannAssist, commented, ‘I am proud of all our team has accomplished to create a leading medical marijuana dispensary. I look forward to continuing our mission and hard work We look forward to the opportunity to be part of one of the top companies in the field. This will ensure that we can provide the highest quality products to patients and customers for many years to come.’
Jon Napoli, Managing Partner, CannAssist, stated, ‘We have been working with the city of Leicester for the past 12 months on this project and are pleased to receive all necessary approvals. This will bring a number of employment opportunities to this community and we look forward to being a reliable partner and producing some of the finest quality cannabis in the state.'”
To view our exclusive interview with Director Andrew Glashow of CLS Holdings USA Inc. Live from Times Square in New York City, please see HD video here: https://www.youtube.com/watch?v=SvNA_pzi4iE
Pyxus International Inc. (NYSE: PYX) is a global agricultural company with 145 years of experience delivering value-added products and services to businesses and customers. Pyxus International Inc. recently announced that its indirect Canadian subsidiary, Goldleaf Pharm Inc., has received its Access to Cannabis for Medical Purposes Regulations (ACMPR) cultivation license from Health Canada. The license, awarded September 28th, 2018, permits Goldleaf Pharm to begin cultivating medicinal cannabis at its Simcoe, Ontario facility. “This is an important step, and an exciting time, for us at Goldleaf Pharm,” said Larry Huszczo, Goldleaf Pharm’s Co-Founder. “We have a state of the art 20,000 square foot indoor growing facility, and recently acquired 20-acres of adjacent property, giving us the ability to expand to more than 700,000 square feet of production space to cultivate cannabis. I am very proud of our team, which has worked diligently to meet Health Canada’s requirements.”
iAnthus Capital Holdings, Inc. (OTCQX: ITHUF) owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. iAnthus Capital Holdings, Inc. and MPX Bioceutical Corporation recently announced that both companies have signed an arrangement agreement pursuant to which iAnthus will combine with MPX in an all-stock transaction with offered equity consideration to MPX shareholders valued at USD 835 Million before giving effect to MPX International and assuming all of MPX’s dilutive securities are exercised prior to the completion of the transaction. The Agreement represents the first public to public merger transaction in U.S. cannabis history. The combined Company, excluding MPX International, will encompass operations and cannabis licenses in 10 states that will permit iAnthus to operate 56 retail locations and 14 cultivation/processing facilities. As a result of the transaction, iAnthus will add retail and/or production capabilities in Arizona, Maryland, Nevada, California and Massachusetts. These additional licenses complement iAnthus’ existing assets in New York, Florida, Massachusetts, Vermont, Colorado, and New Mexico, forming super-regional footprints in both the eastern and western United States.
Origin House (OTCQX: ORHOF) is a growing cannabis products and brands company operating across key markets in the U.S. and Canada, with a strategic focus on becoming a preeminent global house of cannabis brands. CannaRoyalty Corp. (“Origin House”), recently announced that it has registered “Origin House” as a business name and will begin to conduct business under the Origin House name effective immediately. At market open on October 23rd, 2018, the Company’s ticker symbol will change from “CRZ” to “OH” on the Canadian Securities Exchange. The Origin House corporate identity embodies the Company’s strategy to be the preeminent global house of cannabis brands. Marc Lustig, Chairman and Chief Executive Officer of Origin House commented, “I couldn’t be more excited by what we’re building at Origin House. While many public cannabis companies are now attempting to build brands by putting logos on packages, we have already supported the growth of 50+ brand partners. While most other companies have been staking flags across the globe in constrained markets with limited economics or brand building capability, we’ve been operating for years in the largest and most dynamic market in the world, staking flags in what we see as the most valuable real estate out there – consumer mindshare. And now, with the launch of Origin House, we are officially signaling our intention to leverage that mindshare globally.”
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (recently changed from Neptune Technologies & Bioressources Inc.) is a health and wellness products company, with more than 50 years of combined experience in extraction, purification and formulation of value-added differentiated science-based products. Neptune recently announced that it has received a Confirmation of Readiness letter from Health Canada in regard to its application to become a Licensed Producer under the ACMPR (Access to Cannabis for Medical Purposes Regulations). “This key milestone brings us to the threshold of becoming a Licensed Producer of cannabis oil in Canada, and is a very exciting moment,” said Jim Hamilton, President & Chief Executive Officer of Neptune. “Our entry into the legal cannabis industry leverages our established expertise in the development of innovative Omega3 oil products, navigating global regulatory frameworks, worldwide commercialization of wellness solutions, and production of high-quality extracts, as well as our state-of-the-art Good Manufacturing Practices (GMP)-certified facility in Sherbrooke, truly providing us with a strong competitive edge to become a leading player in this burgeoning market”.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.